Abstract
BackgroundLenalidomide, a thalidomide analogue, is indicated for the treatment of multiple myeloma and myelodysplastic syndromes. Knowing the adverse events (AEs) in observational studies is important for detecting those few frequent...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have